[
    [
        {
            "time": "2021-11-11",
            "original_text": "希望破灭！天价药没有双十一大促，120万一针抗癌神药或无缘医保",
            "features": {
                "keywords": [
                    "天价药",
                    "抗癌神药",
                    "医保"
                ],
                "sentiment_score": -0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "希望破灭！天价药没有双十一大促，120万一针抗癌神药或无缘医保",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-11-11",
            "original_text": "雪扬科技起诉复星集团等侵犯商业秘密 诉讼纠纷",
            "features": {
                "keywords": [
                    "雪扬科技",
                    "复星集团",
                    "商业秘密",
                    "诉讼纠纷"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "科技",
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "雪扬科技起诉复星集团等侵犯商业秘密 诉讼纠纷",
                "Correlation": 8,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-11-11",
            "original_text": "斥资8亿，复星再控股一家三级医院",
            "features": {
                "keywords": [
                    "复星",
                    "控股",
                    "三级医院"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "健康服务"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "斥资8亿，复星再控股一家三级医院",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-11-11",
            "original_text": "Wind医药：每日行业动态（2021-11-11）",
            "features": {
                "keywords": [
                    "Wind医药",
                    "行业动态"
                ],
                "sentiment_score": 0.0,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Wind医药：每日行业动态（2021-11-11）",
                "Correlation": 3,
                "Sentiment": 5,
                "Importance": 4,
                "Impact": 3,
                "Duration": 3,
                "Entity_Density": 2,
                "Market_Scope": 6,
                "Time_Proximity": 2,
                "Headline_Structure": 4,
                "Source_Recency": 2
            }
        },
        {
            "time": "2021-11-11",
            "original_text": "国家医保谈判“降价”依旧是主旋律，感染药及PD(L)-1新适应症成角逐热点",
            "features": {
                "keywords": [
                    "国家医保",
                    "降价",
                    "感染药",
                    "PD(L)-1",
                    "新适应症"
                ],
                "sentiment_score": -0.3,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "国家医保谈判“降价”依旧是主旋律，感染药及PD(L)-1新适应症成角逐热点",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        }
    ]
]